Skip to main content

and
  1. Article

    Open Access

    Oncogenic enhancers prime quiescent metastatic cells to escape NK immune surveillance by eliciting transcriptional memory

    Metastasis arises from disseminated tumour cells (DTCs) that are characterized by intrinsic phenotypic plasticity and the capability of seeding to secondary organs. DTCs can remain latent for years before givi...

    Daniela Michelatti, Sven Beyes, Chiara Bernardis, Maria Luce Negri in Nature Communications (2024)

  2. Article

    Open Access

    Recapitulating thyroid cancer histotypes through engineering embryonic stem cells

    Thyroid carcinoma (TC) is the most common malignancy of endocrine organs. The cell subpopulation in the lineage hierarchy that serves as cell of origin for the different TC histotypes is unknown. Human embryon...

    Veronica Veschi, Alice Turdo, Chiara Modica, Francesco Verona in Nature Communications (2023)

  3. Article

    Open Access

    Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51

    Breast cancer (BC) is the second cause of cancer-related deceases in the worldwide female population. Despite the successful treatment advances, 25% of BC develops resistance to current therapeutic regimens, t...

    Alice Turdo, Miriam Gaggianesi, Simone Di Franco, Veronica Veschi in Oncogene (2022)

  4. Article

    Open Access

    Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery

    Obesity is a strong risk factor for cancer progression, posing obesity-related cancer as one of the leading causes of death. Nevertheless, the molecular mechanisms that endow cancer cells with metastatic prope...

    Simone Di Franco, Paola Bianca, Davide Stefano Sardina in Nature Communications (2021)

  5. No Access

    Chapter

    Cancer Stem Cells: From Birth to Death

    Conspicuous investigations have proven the role of cancer stem cells (CSCs) in the onset and progression of a plethora of liquid and solid neoplasms. CSCs are endowed with the capability of initiating tumor gr...

    Alice Turdo, Miriam Gaggianesi in Cancer Stem Cell Resistance to Targeted Th… (2019)

  6. Article

    Open Access

    Author Correction: MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state

    The original version of this Article contained an error in the spelling of the author Miriam Gaggianesi, which was incorrectly given as Miriam Giaggianesi. Furthermore, the affiliation details for Gabriella Ga...

    Vittoria Poli, Luca Fagnocchi, Alessandra Fasciani in Nature Communications (2018)

  7. Article

    Open Access

    MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state

    Breast cancer consists of highly heterogeneous tumors, whose cell of origin and driver oncogenes are difficult to be uniquely defined. Here we report that MYC acts as tumor reprogramming factor in mammary epit...

    Vittoria Poli, Luca Fagnocchi, Alessandra Fasciani in Nature Communications (2018)

  8. No Access

    Chapter

    Targeting Cancer Stem Cells and the Tumor Microenvironment

    Compelling evidence indicates that the survival and behavior of cancer stem cells (CSCs) are positively regulated by specific stimuli received from the tumor microenvironment, which dictates the maintenance of...

    Alice Turdo, Matilde Todaro, Giorgio Stassi in Cancer Stem Cells: Emerging Concepts and F… (2015)